{"title":"The Association of Periodontitis With Risk of Prevalent and Incident Metabolic Syndrome.","authors":"Jenni Kinnunen,Kari Koponen,Oleg Kambur,Muhammed Manzoor,Katariina Aarnisalo,Verneri Nissilä,Satu Männistö,Veikko Salomaa,Pekka Jousilahti,Eija Könönen,Ulvi Kahraman Gürsoy,Aki S Havulinna,Aino Salminen,Pirkko Pussinen","doi":"10.1111/jcpe.70042","DOIUrl":null,"url":null,"abstract":"AIM\r\nTo investigate whether periodontitis is associated with prevalent and incident metabolic syndrome (MetS).\r\n\r\nMATERIALS AND METHODS\r\nThe baseline study included 4183 individuals from a population-based survey (DILGOM) in 2007 and follow-up of 1047 participants with clinical re-examination in 2014. The risk of periodontitis was assessed with saliva biomarkers using a validated, three-group cumulative risk score for periodontitis (CRS I, II and III).\r\n\r\nRESULTS\r\nIn fully adjusted models, CRS III was associated with prevalent MetS (OR: 1.35, 95% CI [1.11-1.65]), high waist circumference (1.55 95% CI [1.26-1.91]), high blood pressure (1.29 95% CI [1.05-1.59]) and the number of MetS components (β: 0.18, 95% CI [0.06-0.30]). Among participants without MetS at baseline (n = 618), 128 (20.7%) developed MetS during follow-up. In the fully adjusted model, CRS III trended positively with incident MetS (RR: 1.55, 95% CI [ 0.96-2.51]) in the whole population and had a significant positive association in women (2.06, 95% CI [1.08-3.94]), and in non-smokers (1.78, 95% CI [1.01-3.14]). The risk between CRS and incident MetS was mediated via systemic inflammation.\r\n\r\nCONCLUSION\r\nPeriodontitis is associated with an increased risk of having metabolic syndrome and, in particular, clearly with the number of MetS components: abdominal obesity, hyperglycaemia and hypertension. Systemic inflammation may elucidate the observed higher risk of incident MetS.","PeriodicalId":15380,"journal":{"name":"Journal of Clinical Periodontology","volume":"17 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Periodontology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jcpe.70042","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
AIM
To investigate whether periodontitis is associated with prevalent and incident metabolic syndrome (MetS).
MATERIALS AND METHODS
The baseline study included 4183 individuals from a population-based survey (DILGOM) in 2007 and follow-up of 1047 participants with clinical re-examination in 2014. The risk of periodontitis was assessed with saliva biomarkers using a validated, three-group cumulative risk score for periodontitis (CRS I, II and III).
RESULTS
In fully adjusted models, CRS III was associated with prevalent MetS (OR: 1.35, 95% CI [1.11-1.65]), high waist circumference (1.55 95% CI [1.26-1.91]), high blood pressure (1.29 95% CI [1.05-1.59]) and the number of MetS components (β: 0.18, 95% CI [0.06-0.30]). Among participants without MetS at baseline (n = 618), 128 (20.7%) developed MetS during follow-up. In the fully adjusted model, CRS III trended positively with incident MetS (RR: 1.55, 95% CI [ 0.96-2.51]) in the whole population and had a significant positive association in women (2.06, 95% CI [1.08-3.94]), and in non-smokers (1.78, 95% CI [1.01-3.14]). The risk between CRS and incident MetS was mediated via systemic inflammation.
CONCLUSION
Periodontitis is associated with an increased risk of having metabolic syndrome and, in particular, clearly with the number of MetS components: abdominal obesity, hyperglycaemia and hypertension. Systemic inflammation may elucidate the observed higher risk of incident MetS.
期刊介绍:
Journal of Clinical Periodontology was founded by the British, Dutch, French, German, Scandinavian, and Swiss Societies of Periodontology.
The aim of the Journal of Clinical Periodontology is to provide the platform for exchange of scientific and clinical progress in the field of Periodontology and allied disciplines, and to do so at the highest possible level. The Journal also aims to facilitate the application of new scientific knowledge to the daily practice of the concerned disciplines and addresses both practicing clinicians and academics. The Journal is the official publication of the European Federation of Periodontology but wishes to retain its international scope.
The Journal publishes original contributions of high scientific merit in the fields of periodontology and implant dentistry. Its scope encompasses the physiology and pathology of the periodontium, the tissue integration of dental implants, the biology and the modulation of periodontal and alveolar bone healing and regeneration, diagnosis, epidemiology, prevention and therapy of periodontal disease, the clinical aspects of tooth replacement with dental implants, and the comprehensive rehabilitation of the periodontal patient. Review articles by experts on new developments in basic and applied periodontal science and associated dental disciplines, advances in periodontal or implant techniques and procedures, and case reports which illustrate important new information are also welcome.